Home > Healthcare > Medical Devices > Diagnostic Devices > Blood Culture Tests Market

Blood Culture Tests Market Size

Report ID: GMI7701
Published Date: Dec 2023
Report Format: PDF

Download Free Sample

Blood Culture Tests Market Size

Blood Culture Tests Market was valued at USD 5.8 billion in 2023 and is estimated to showcase about 7.9% CAGR between 2024 and 2032. Driven by the rising incidence of bacterial infections and other related conditions is likely to elevate the need for blood culture tests as confirmatory diagnostic procedures. Furthermore, technological advancements, particularly in automated systems, are improving the efficiency and accuracy of blood culture tests.

To get key market trends

Download Free Sample

Rising global healthcare expenditure is facilitating the adoption of advanced diagnostic solutions, while the trend towards point of care testing, which is estimated to account for USD 78.3 billion by 2032, is influencing the development of faster and more convenient options, thereby accelerating market growth.

Blood Culture Tests Market Report Attributes
Report Attribute	Details
Base Year:	2023
Blood Culture Tests Market Size in 2023:	USD 5.8 Billion
Forecast Period:	2024 to 2032
Forecast Period 2024 to 2032 CAGR:	7.9%
2032 Value Projection:	USD 11.5 Billion
Historical Data for:	2018 to 2023
No. of Pages:	235
Tables, Charts & Figures:	621
Segments covered:	Product, Method, Technology, Application, End-use, and Region
Growth Drivers:	Surge in prevalence of infectious diseases Increasing government initiatives towards infectious diseases Technological advancements regarding blood culture tests Rising awareness regarding infectious diseases and its diagnosis
Pitfalls & Challenges:	High costs associated with blood culture testing Stringent regulatory framework

Learn more about the key segments shaping this market

Download Free Sample

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of blood culture tests was worth USD 5.8 billion in 2022 and is estimated to reach USD 11.5 billion by 2032 as these tests are crucial in identifying and diagnosing bloodstream infections, which can be serious and life-threatening if not promptly treated.

The consumables segment garnered USD 3.5 billion in 2023 and will grow significantly through 2032, due to an increased emphasis on the quality of culture media.

U.S. blood culture tests market accounted for USD 2.2 billion in 2023 and is predicted to witness substantial growth through 2032, owing to the increasing healthcare investments, a rising burden of infectious and chronic diseases, and efforts to expand healthcare access.

Becton, Dickinson and Company, Terumo Corporation, bioMerieux SA, Bruker Corporation, T2 Biosystems Inc., Abbott Laboratories, Luminex Corporation, Siemens Healthineers AG, F. Hoffmann-La Roche AG, Danaher Corporation, Neogen Corporation, and Thermo Fisher Scientific Inc.